Max Healthcare Institute Limited has announced that its Renewable Energy and Subsidiary Investment Committee (RESIC) has approved an infusion of ₹87.87 crore into its subsidiary, Kalinga Hospital Ltd. The funds will be provided through a subscription to equity shares on a rights basis. This capital injection is intended to support Kalinga Hospital’s capital expenditure, modernization efforts, and general corporate requirements.
Capital Infusion for Subsidiary
Max Healthcare Institute Limited has received approval from its Renewable Energy and Subsidiary Investment Committee (RESIC) to infuse an additional ₹87.87 crore into its subsidiary, Kalinga Hospital Ltd. This strategic financial move will be executed through a subscription to equity shares of Kalinga Hospital on a rights basis.
Strategic Objectives of the Investment
The primary objective behind this significant capital infusion is to bolster Kalinga Hospital Ltd.’s operational capabilities. The funds are earmarked to support the subsidiary’s crucial capital expenditure and modernization programmes. Furthermore, this investment aims to strengthen the hospital’s clinical and operational capacities, optimize its capital structure, and meet its general corporate requirements, ensuring its continued growth and development within the healthcare sector.
Transaction Details
The RESIC meeting where this approval was granted took place on September 3, 2026, commencing at 2:50 PM IST and concluding at 3:22 PM IST. The consideration for this acquisition is a cash consideration of approximately ₹87.87 crore. The acquisition is expected to be completed within the next 15 days.
Kalinga Hospital Ltd. operates within the Healthcare Services industry and is an existing subsidiary of Max Healthcare Institute Limited. Its Paid-up Capital stands at ₹21.54 crore, with a Revenue from Operations during FY 2025-26 reported at approximately ₹155.64 crore. The company anticipates that the exact percentage of shareholding and the number of shares acquired will be available upon the allotment of shares pursuant to the Rights Issue of Kalinga Hospital.
Source: BSE
